2025 HOUSE AND SENATE SESSION JOB OPPORTUNITIES AVAILABLE NOW

Measure Title: RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.
Report Title: Right-to-Try Act; Terminally Ill Patients; Investigational Drugs; Biological Products
Description: Beginning on 1/1/2024, permits manufacturers of investigational drugs or biological products to make these drugs and products available to terminally ill patients under certain conditions. Effective 7/1/3000. (HD1)
Companion:  SB857
Package: None
Current Referral: HLT, CPC, FIN
Introducer(s): BELATTI, AMATO, GANADEN, GATES, HUSSEY-BURDICK, LAMOSAO, MARTEN, MATAYOSHI, MIZUNO, NAKASHIMA, NISHIMOTO, PERRUSO, TAKENOUCHI, TARNAS, TODD, Poepoe
Act:

Sort by Date Status Text
2/8/2024HPassed Second Reading as amended in HD 1 and referred to the committee(s) on CPC with none voting aye with reservations; none voting no (0) and Representative(s) Nakashima, Nishimoto, Sayama, Ward excused (4).
2/8/2024HReported from HLT (Stand. Com. Rep. No. 199-24) as amended in HD 1, recommending passage on Second Reading and referral to CPC.
2/7/2024HThe committee on HLT recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Belatti, Takenouchi, Amato, Ilagan, Kobayashi, Marten, Nishimoto, Garcia; Ayes with reservations: none; Noes: none; and Excused: none.
2/2/2024HBill scheduled to be heard by HLT on Wednesday, 02-07-24 9:45AM in House conference room 329 VIA VIDEOCONFERENCE.
12/11/2023DCarried over to 2024 Regular Session.
1/30/2023HReferred to HLT, CPC, FIN, referral sheet 3
1/25/2023HIntroduced and Pass First Reading.
1/23/2023HPending introduction.

S = Senate | H = House | D = Data Systems | $ = Appropriation measure | ConAm = Constitutional Amendment

Some of the above items require Adobe Acrobat Reader. Please visit Adobe's download page for detailed instructions.


HB966 HD1
All Versions of this Measure
Committee Reports
Hearing Notices
HLT
2/07/24 9:45A
329 VIA VIDEOCONFERENCE